The PAH Platform for Deep Phenotyping in Korean Subjects

NCT03933579 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2019-05-01

No results posted yet for this study

Summary

A total of 16 regional hospitals will be registering clinical data and biological specimens of idiopathic pulmonary arterial hypertension (IPAH)/heritable pulmonary arterial hypertension (HPAH) patients across Korea. The diagnosis of pulmonary arterial hypertension(PAH) will be based on right heart catheterization, where PAH caused by etiology other than HPAH or IPAH will be excluded. All clinical data will be stored to a government-based online database. Each participating hospitals will be collecting whole blood from each patient, through which DNA, RNA, serum, plasma, and peripheral blood mononuclear cells will be extracted from the buffy coat layer for further multi-omics analysis.

Conditions

Interventions

DIAGNOSTIC_TEST

Deep phenotyping

Each participating hospitals will be collecting whole blood from each patient, through which DNA, RNA, serum, plasma, and peripheral blood mononuclear cells will be extracted from the buffy coat layer for further multi-omics analysis.

Sponsors & Collaborators

  • Sejong General Hospital

    collaborator OTHER
  • Chonnam National University Hospital

    collaborator OTHER
  • Keimyung University Dongsan Medical Center

    collaborator OTHER
  • Saint Vincent's Hospital, Korea

    collaborator OTHER
  • Seoul National University

    collaborator OTHER
  • Chungnam National University Hospital

    collaborator OTHER
  • Wonju Severance Christian Hospital

    collaborator OTHER
  • Asan Medical Center

    collaborator OTHER
  • Wonkwang University Hospital

    collaborator OTHER
  • Chungbuk National University Hospital

    collaborator OTHER
  • Samsung Medical Center

    collaborator OTHER
  • Severance Hospital

    collaborator OTHER
  • The Catholic University of Korea

    collaborator OTHER
  • Seoul National University Bundang Hospital

    collaborator OTHER
  • Pusan National University Hospital

    collaborator OTHER
  • Chonbuk National University Hospital

    collaborator OTHER
  • Pusan National University Yangsan Hospital

    collaborator OTHER
  • Gachon University Gil Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03933579 on ClinicalTrials.gov